A large study on immunological response to a whole-cell killed oral cholera vaccine reveals that there are significant geographical differences in response and that O blood group individuals do not elicit a higher response

Clinical and Vaccine Immunology

Volumn 17, Issue 8, 2010, Pages 1232-1237

  Ramamurthy, T ^a   Wagener, Diane ^b   Chowdhury, Goutam ^a   Majumder, Partha P ^c  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b RTI INTERNATIONAL   (United States)

^c INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; BACTERIUM ANTIBODY; BLOOD GROUP ANTIGEN; INACTIVATED VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; CHOLERA; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; GENE FREQUENCY; GEOGRAPHIC DISTRIBUTION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; BLOOD; IMMUNOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BLOOD GROUP ANTIGENS; CHOLERA; CHOLERA VACCINES; ENDEMIC DISEASES; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 77955296403     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00123-10     Document Type: Article

References (12)

1. Anh, D. D., D. G. Canh, A. L. Lopez, V. D. Thiem, P. T. Long, N. H. Son, J. Deen, L. von Seidlein, R. Carbis, S. H. Han, S. H. Shin, S. Attridge, J. Holmgren, and J. Clemens. 2007. Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine 25:1149-1155.
2. Benenson, A. S., A. Saad, and W. H. Mosley. 1968. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique. Bull. World Health Organ. 38:277-285.
3. Clemens, J. D., D. A. Sack, J. R. Harris, J. Chakraborty, M. R. Khan, S. Huda, F. Ahmed, J. Gomes, M. R. Rao, and A. M. Svennerholm. 1989. ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy. J. Infect. Dis. 159:770-773.
4. Cooper, P. J., M. E. Chico, G. Lasonsky, C. Sandoval, I. Espinel, R. Sridhara, M. Aguilar, A. Guevara, R. H. Guderian, M. M. Levine, G. E. Griffin, and T. B. Nutman. 2000. Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. J. Infect. Dis. 182:1199-1206.
5. Glass, R. I., J. Holmgren, C. E. Haley, M. R. Khan, A. M. Svennerholm, B. J. Stoll, K. M. B. Hossain, R. E. Black, M. Yunus, and D. Barua. 1985. Predisposition for cholera of individuals with O blood group: possible evolutionary significance. Am. J. Epidemiol. 121:791-796.
6. Harris, J. B., A. I. Khan, R. C. LaRocque, D. J. Dorer, F. Chowdhury, A. S. Faruque, D. A. Sack, E. T. Ryan, F. Qadri, and S. B. Calderwood. 2005. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect. Immun. 73:7422-7427.
7. Institute of Medicine. 1986. New vaccine development: establishing priorities, vol. II. Diseases of importance in developing countries. National Academy Press, Washington, DC.
8. Lagos, R., A. Avendaño, V. Prado, I. Horwitz, S. Wasserman, G. Losonsky, S. Cryz, Jr., J. B. Kaper, and M. M. Levine. 1995. Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O. Infect. Immun. 63:707-709.
9. Mahalanabis, D., A. L. Lopez, D. Sur, J. Deen, B. Manna, S. Kanungo, L. von Seidlein, R. Carbis, S. H. Han, S. H. Shin, S. Attridge, R. Rao, J. Holmgren, J. Clemens, and S. K. Bhattacharya. 2008. A randomized, placebo- controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS One 3:e2323. doi:10.1371/journal.pone. 0002323.
10. Majumder, P. P., and J. Roy. 1982. Distribution of ABO blood groups on the Indian subcontinent: a cluster-analytic approach. Curr. Anthrop. 23:539-566.
11. World Health Organization Global Task Force on Cholera Control. 2002. Cholera vaccines: a new public health tool? Report of a WHO meeting, 10 to 11 December 2002. World Health Organization, Geneva, Switzerland.
12. World Health Organization. 2007. Cholera 2006. Wkly. Epidemiol. Rec. 82:273-284.